RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
Impact
The introduction of H7744 is expected to have a considerable impact on state laws governing accident and sickness insurance policies. By requiring insurers to offer multiple delivery options, the bill aims to enhance competition among pharmacies and improve healthcare access for patients. It could potentially lead to better pricing and service as insurers and pharmacies may work to attract more customers under these new requirements. Additionally, it may address concerns about accessibility for individuals who may face challenges with mail order services.
Summary
House Bill H7744 aims to amend existing insurance laws in Rhode Island concerning drug coverage under group health plans. The primary objective of the bill is to ensure that all group health insurers provide patients with a minimum of two options for delivering prescription drugs. This change is significant as it seeks to promote better access to medications for patients, allowing them flexibility in how they receive their prescriptions. The bill also prohibits insurers from mandating that insured individuals obtain their prescription drugs exclusively from mail order pharmacies, further enhancing the choices available to consumers.
Contention
While the bill has sparked support from various stakeholders who advocate for patient rights and improved access to healthcare, it may also face resistance from insurers and pharmacy benefit managers. Critics may argue that mandating multiple delivery options could lead to increased operational costs or complexities in compliance for insurance companies. As discussions continue, it's crucial to weigh these opposing viewpoints to ensure the bill effectively balances consumer needs with the operational realities of insurers.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Requires individual and group health insurance policies that provide pregnancy-related benefits to cover medically necessary expenses for diagnosis and treatment of infertility and standard fertility-preservation services.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.